Xiao-fei Shen

Dr. Xiao-fei Shen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
LZLin Zhao
Lin Zhao
LWLun Wang
Lun Wang
SDSuo-Ni Di
Suo-Ni Di
QXQian Xu
Qian Xu
QRQing-Cuo Ren
Qing-Cuo Ren
XSXiao-fei Shen
Xiao-fei Shen

17 June 2019 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
QRQing‐Cuo Ren
Qing‐Cuo Ren
XLXuan‐Hao Li
Xuan‐Hao Li
QLQiu‐Yue Li
Qiu‐Yue Li
HYHai‐Ling Yang
Hai‐Ling Yang
HWHong‐Ling Wang
Hong‐Ling Wang
XSXiao-fei Shen
Xiao-fei Shen

1 July 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
FXFan Xie
Fan Xie
HZHai Zhang
Hai Zhang
CZChuan Zheng
Chuan Zheng
XSXiao-fei Shen
Xiao-fei Shen

19 April 2018 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
LZLin Zhao
Lin Zhao
STShuai Tan
Shuai Tan
HZHai Zhang
Hai Zhang
PLPeng Liu
Peng Liu
YTYu‐Zhu Tan
Yu‐Zhu Tan
XSXiao-fei Shen
Xiao-fei Shen

24 January 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HZHai Zhang
Hai Zhang
YTYu-Ping Tan
Yu-Ping Tan
LZLin Zhao
Lin Zhao
LWLun Wang
Lun Wang
NFNai-Jie Fu
Nai-Jie Fu
XSXiao-fei Shen
Xiao-fei Shen
Hepatocellular carcinoma (HCC) is one of the most lethal human cancers worldwide. The dietary xanthone α-mangostin (α-MGT) exhibits potent anti-tumor effects in vitro and in vivo. However, the anti-HCC effects of α-MGT and their underlying mechanisms are still vague. Aberrant activation of signal transducer and activator of transcription 3 (STAT3) is involved in the progression of HCC. We therefore investigated whether α-MGT inhibited the activation of STAT3 and thereby exhibits its anti-HCC effects. In this study, we found that α-MGT significantly suppressed cell proliferation, induced cell cycle arrest, and triggered apoptosis in HCC cells, including HepG2, SK-Hep-1, Huh7, and SMMC-7721 cells in vitro, as well as inhibiting tumor growth in nude mice bearing HepG2 or SK-Hep-1 xenografts. Furthermore, α-MGT potently inhibited the constitutive and inducible activation of STAT3 in HCC cells. In addition, α-MGT also suppressed IL-6-induced dimerization and nuclear translocation of STAT3, which led to inhibition of the expression of STAT3-regulated genes at both mRNA and protein levels. Mechanistically, α-MGT exhibited effective inhibition of the activation of STAT3’s upstream kinases, including JAK2, Src, ERK, and Akt. Importantly, α-MGT increased the protein level of Src homology region 2 domain-containing phosphatase-1 (SHP1), which is a key negative regulator of the STAT3 signaling pathway. Furthermore, α-MGT enhanced the stabilization of SHP1 by inhibiting its degradation mediated by the ubiquitin–proteasome pathway. Knockdown of SHP1 using siRNA obviously prevented the α-MGT-mediated inhibition of the activation of STAT3 and proliferation of HCC cells. In summary, α-MGT exhibited a potent anti-HCC effect by blocking the STAT3 signaling pathway via the suppression of the degradation of SHP1 induced by the ubiquitin–proteasome pathway. These findings also suggested the potential of dietary derived α-MGT in HCC therapy.

1 March 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JQJunhong Qin
Junhong Qin
XSXiao-fei Shen
Xiao-fei Shen
JZJian Zhang
Jian Zhang
Da JiaDa Jia
Da Jia